Food and Drug Administration, HHS.
The Food and Drug Administration (FDA or Agency) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA).
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
End Further Info
Start Supplemental Information
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at http://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
Table 1—List of Information Collections Approved by OMB
|Title of collection||OMB control No.||Date approval expires|
|Physician Interpretation of Information About Prescription Drugs in Scientific Publications Versus Promotional Pieces||0910-0875||9/30/2021|
|Guidance on Meetings with Industry and Investigators on the Research and Development of Tobacco Products||0910-0731||8/31/2022|
|Start Printed Page 57451|
|Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under the Federal Food, Drug, and Cosmetic Act||0910-0732||8/31/2022|
|Tobacco Products, User Fees, Requirements for the Submission of Data Needed to Calculate User Fees for Domestic Manufacturers and Importers of Tobacco||0910-0749||8/31/2022|
|Guidance for Industry on Establishing That a Tobacco Product Was Commercially Marketed in the United States as of February 15, 2007||0910-0775||8/31/2022|
|Medicated Feed Mill License Application||0910-0337||9/30/2022|
|Guidance on Informed Consent for In Vitro Diagnostic Studies Using Leftover Human Specimens That Are Not Individually Identifiable||0910-0582||9/30/2022|
|Manufactured Food Regulatory Program Standards||0910-0601||9/30/2022|
|Information to Accompany Humanitarian Device Exemption Applications and Annual Distribution Number Reporting Requirements||0910-0661||9/30/2022|
|Generic Clearance for Quick Turnaround Testing of Communication Effectiveness||0910-0876||9/30/2022|
End Supplemental Information
Dated: October 17, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-23251 Filed 10-24-19; 8:45 am]
BILLING CODE 4164-01-P